J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Receipt Of ANDA Approval For Doxepin Hydrochloride Capsules USP From US FDA

J B Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1732.0000 8.60 (0.50%)

NSE Sep 05, 2025 10:16 AM

Volume: 24,484

J B Chemicals & Pharmaceuticals Ltd.

23 Aug 2023

1732.00

0.50%

Company Update

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Receipt Of ANDA Approval For Doxepin Hydrochloride Capsules USP …

BSE India

Receipt of ANDA approval for Doxepin Hydrochloride Capsules USP from US FDA

More from J B Chemicals & Pharmaceuticals Ltd.

Recommended

Market opens higher, Biocon gets Form 483 with 5 observations from the US FDA for its Bengaluru facility

Trendlyne Marketwatch | 05 Sep 2025, 10:01AM

Retail investor wave powers mutual funds to record momentum

The Baseline | 04 Sep 2025, 04:05PM

New leadership, fresh strategy at JB Chemicals sees impact in Q1FY23